📰 Cell Entry News
Cell Entry News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Entry. Real-time updates on events, politics, business and more.
June 23, 2023
This randomized clinical trial compares the effects of 3 doses of bamlanivimab monotherapy (700 vs 2800 vs 7000 mg) vs combination bamlanivimab and etesevimab v
December 29, 2020
Share this article Share this article PLANO, Texas, Dec. 29, 2020 /PRNewswire/ -- U.S. Renal Care (USRC), a leading provider of dialysis services caring for more than 26,000 individuals living with kidney disease, announced it will obtain and distribute the monoclonal antibody therapy, Bamlanivimab, to its patients recently diagnosed with COVID-19. USRC obtained the therapy from Operation Warp Speed, Project SPEED, and will administer the drug to medically stable COVID-19 positive patients wit...